arrow
K

Kwang-Yeol Park

keimyung university
H指数:34
被引数:4,367

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

比较氯吡格雷为基础的抗血小板治疗与华法林作为抗磷脂综合征相关卒中(APS-STROKE)二级预防策略的对照研究:一项前瞻性、随机、开放标签、盲终点试验的方案与设计

2025-12-010
PRE
Effect of atorvastatin versus no Statin Treatment on major clinical events in Acute CardioEmbolic stroke patients without a definite indication for statin therapy: protocol for the STACE trial

阿托伐他汀与无他汀治疗对无明确他汀治疗指征的急性心源性卒中患者主要临床事件的影响:STACE试验方案

2025-09-260
OAAI
Subtype shift, relapse rate and risk factors of frequent relapse in cluster headache: A multicenter, prospective, longitudinal observation

丛集性头痛的亚型转变、复发率及频繁复发的危险因素:一项多中心、前瞻性、纵向观察研究

2025-09-130
OA
Therapeutic Potential of Porcine Brain-Derived Peptide Mixture (PBDP) in Alzheimer’s Disease: An Exploratory Study on Quantitative Electroencephalography (qEEG) Changes

猪脑源性肽混合物(PBDP)在阿尔茨海默病中的治疗潜力:一项关于定量脑电图(qEEG)变化的探索性研究

2025-09-050
OAAI
Exploring the efficacy and safety of dual antiplatelet therapy in patients with embolic stroke of undetermined source according to stroke risk stratification: Propensity-score matched analysis

探索根据卒中风险分层,对不明原因栓塞型卒中患者行双联抗血小板治疗的疗效和安全性:倾向性评分匹配分析

2025-09-010
OA
Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial

奥赛拉цетам和体育活动在预防卒中后认知衰退中的作用:一项多中心、随机对照试验

2025-07-270
PRE
Temporal patterns of occult cancer incidence following acute ischemic stroke: A comparative study by stroke etiology

急性缺血性卒中后隐匿性癌发生的时间模式:一项按卒中病因进行的比较研究

2025-04-090
PRE
Temporal Trends in Stroke Management and Outcomes Between 2011 and 2020 in South Korea: Results From a Nationwide Multicenter Registry
2025-02-190
OAAI
Long-Term Incidence of Gastrointestinal Bleeding Following Ischemic Stroke

缺血性卒中后胃肠道出血的长期发生率

stroke
IF8.6
2025-01-310
OA
Impact of non-traditional lipid profiles on 1-year vascular outcomes in ischemic stroke patients with prior statin therapy and LDL-C < 100 mg/dL
2024-10-010
OAAI
Differential impacts of admission LDL-cholesterol on early vascular outcomes by ischemic stroke subtypes
2024-03-011
PRE
Efficacy of Endovascular Thrombectomy in Acute Basilar Artery Occlusion with Low PC-ASPECTS: A Nationwide Prospective Registry-Based Study
2024-02-214
PRE
D-dimer to fibrinogen ratio predicts early neurological deterioration in ischemic stroke with atrial fibrillation (vol 229, pg 219, 2023)
2024-01-010
OAAI
An Analysis of the Determinants of the Health-Related Quality of Life in Asian Patients With Cluster Headaches During Cluster Periods Using the Time Trade-Off Method
2024-01-011
OAAI
Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
2024-01-010
OAAI
Statin Treatment in Patients With Stroke With Low-Density Lipoprotein Cholesterol Levels Below 70 mg/dL
2023-09-194
OAAI
Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
stroke
IF8.6
2023-05-315
OAAI
Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial: Rationale and design
2023-04-250
PRE